Description
MyHep All™ is a licensed generic of Epclusa® produced by Mylan Pharmaceuticals Ltd®, a US FDA certified manufacturer, in India. It’s a direct-acting antiviral used to treat Chronic Hepatitis C (HCV) across all genotypes in patients with or without liver cirrhosis. For most patients, 12 weeks of treatment is needed to reach cure.
Bottle Size : 28 Tablets (4 weeks supply)
Active Ingredients : Sofosbuvir 400 mg / Velpatasvir 100 mg
Produced by Mylan Pharmaceuticals®